Tofidence is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Tofidence is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameTofidence
Authorized generictocilizumab
Regular generictocilizumab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Tofidence?
The original
–
–

Brand nameThe maker’s card

Organon Co-pay Assistance Program (TOFIDENCE)

Savings card from Organon

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 an infusion

Sign up on tofidence.com 

Or call 1-866-809-9515.

In the maker’s words

“Once enrolled, eligible, privately insured patients could pay as little as $0 of their co-pay per infusion.”

From the maker’s offer on tofidence.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Tofidence itself, from the same company, sold without the brand name, and usually for less. For now Tofidence is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Tofidence is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

TOFIDENCE® (tocilizumab-bavi) is an interleukin-6 (IL-6) receptor antagonist indicated for treatment of:

Rheumatoid Arthritis (RA)

  • Adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs).

Giant Cell Arteritis (GCA)

  • Adult patients with giant cell arteritis.

Polyarticular Juvenile Idiopathic Arthritis (PJIA)

  • Patients 2 years of age and older with active polyarticular juvenile idiopathic arthritis.

Systemic Juvenile Idiopathic Arthritis (SJIA)

  • Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.

Cytokine Release Syndrome (CRS)

  • Adults and pediatric patients 2 years of age and older with chimeric antigen receptor (CAR) T cell-induced severe or life-threatening cytokine release syndrome.

Coronavirus Disease 2019 (COVID-19)

  • Hospitalized adult and pediatric patients aged 2 years and older with coronavirus disease 2019 (COVID-19) who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

Source: the FDA label for Tofidence (Organon LLC), May 22, 2026. Full label on DailyMed 

Good to know